Clinical Trial Update: An Open-Label Study of N-Acetyl Cysteine in Children With Autism [Phase 2]

View source ↗

Summary

Open-label Phase 2 study evaluating N-acetylcysteine in children with autism has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Stanford University | Conditions: Autistic Disorder | Phase 2 | Status: COMPLETED | Results posted: 2017-03-29